The application of
antimicrobial peptides has emerged as an alternative
therapeutic tool to encounter against multidrug resistance of different
pathogenic organisms. α-Melanocyte stimulating hormone (α-MSH),
an endogenous neuropeptide, is found to be efficient in eradicating
infection of various kinds of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). However, the chemical stability and efficient delivery of
these biopharmaceuticals (i.e., α-MSH) to bacterial cells with
a significant antibacterial effect remains a key challenge. To address
this issue, we have developed a chitosan-cholesterol polymer using
a single-step, one-pot, and simple chemical conjugation technique,
where α-MSH is loaded with a significantly high amount (37.7%),
and the final product is obtained as chitosan-cholesterol α-MSH
polymer–drug nanoconjugates. A staphylococcal growth inhibition
experiment was performed using chitosan-cholesterol α-MSH and
individual controls. α-MSH and chitosan-cholesterol both show
bacterial growth inhibition by a magnitude of 50 and 79%, respectively.
The killing efficiency of polymer–drug nanoconjugates was very
drastic, and almost no bacterial colony was observed (∼100%
inhibition) after overnight incubation. Phenotypic alternation was
observed in the presence of α-MSH causing changes in the cell
structure and shape, indicating stress on Staphylococcus
aureus. As a further consequence, vigorous cell lysis
with concomitant release of the cellular material in the nearby medium
was observed after treatment of chitosan-cholesterol α-MSH nanoconjugates.
This vigorous lysis of the cell structure is associated with extensive
aggregation of the bacterial cells evident in scanning electron microscopy
(SEM). The dose-response experiment was performed with various concentrations
of chitosan-cholesterol α-MSH nanoconjugates to decipher the
degree of the bactericidal effect. The concentration of α-MSH
as low as 1 pM also shows significant inhibition of bacterial growth
(∼40% growth inhibition) of Staphylococcus aureus. Despite playing an important role in inhibiting bacterial growth,
our investigation on hemolytic assay shows that chitosan-cholesterol
α-MSH is significantly nontoxic at a wide range of concentrations.
In a nutshell, our analysis demonstrated novel antimicrobial activity
of nanoparticle-conjugated α-MSH, which could be used as future
therapeutics against multidrug-resistant Staphylococcus
aureus and other types of bacterial cells.